From mice to humans: developments in cancer immunoediting

Cited by (337)

Items 201–300 of 337

1. Revolutionizing Skin Cancer Treatment: The Rise of PD-1/PDL-1 and CTLA-4 as Key Therapeutic Targets
   Neha Sharma, Rupa Mazumder, Pallavi Rai · 2024 · Current Drug Targets
2. Immunotherapeutic strategies to induce inflection in the immune response: therapy for cancer and COVID-19
   Saba Hasan, Prankur Awasthi, Sumira Malik, Manish Dwivedi · 2022 · Biotechnology and Genetic Engineering Reviews
3. Biophysical Control of the Glioblastoma Immunosuppressive Microenvironment: Opportunities for Immunotherapy
   Landon Teer, Kavitha Yaddanapudi, Joseph Chen · 2024 · Bioengineering
4. Immunoediting Dynamics in Glioblastoma: Implications for Immunotherapy Approaches
   Tasbir Amin, Amana Hossain, Nusrat Jerin, Imteaz Mahmud, Md Ahasanur Rahman, S.M. Rafiqul Islam, S M Bakhtiar UL Islam · 2024 · Cancer Control
5. Engineering and biofabrication of early cancer models
   Haylie R. Helms, Alexander E. Davies, Carolyn E. Schutt, Ellen M. Langer, Rebekka Duhen, Prima Dewi Sinawang, Demir Akin, Utkan Demirci, Sadik C. Esener, Rebecca Claire Fitzgerald et al. · 2025 · Nature Reviews Bioengineering
6. Overview of Basic Immunology and Translational Relevance for Clinical Investigators
   Bettzy Stephen, Joud Hajjar · 2018 · Advances in experimental medicine and biology
7. Cancer Immunosurveillance: Immunoediting
   Danielle M. Lussier, Robert D. Schreiber · 2016 · Elsevier eBooks
8. The Prognostic Role of the Immune Microenvironment in Sinonasal Intestinal-Type Adenocarcinoma: A Computer-Assisted Image Analysis of CD3+ and CD8+ Tumor-Infiltrating Lymphocytes
   Marco Ferrari, Lara Alessandrini, Enrico Savietto, Diego Cazzador, Gloria Schiavo, Stefano Taboni, Andrea Luigi Camillo Carobbio, Leonardo Calvanese, Giacomo Contro, Piergiorgio Gaudioso et al. · 2023 · Journal of Personalized Medicine
9. Effective extracellular vesicles in glioma: Focusing on effective ncRNA exosomes and immunotherapy methods for treatment
   Sulieman Ibraheem Shelash Al‐Hawary, Sharif Alhajlah, Bokov Dmitry Olegovich, Ahmed M. Hjazi, Pranchal Rajput, Saad Hayif Jasim Ali, Munther Abosoda, Ali Ihsan, Shamam Kareem Oudah, Yasser Fakri Mustafa · 2024 · Cell Biochemistry and Function
10. Mitigating non-genetic resistance to checkpoint inhibition based on multiple states of immune exhaustion
    Irina Kareva, Jana L. Gevertz · 2024 · npj Systems Biology and Applications
11. Decoding Immune Signature to Detect the Risk for Early-Stage HCC Recurrence
    Aswathy R. Devan, Bhagyalakshmi Nair, Kanjoormana Aryan Manu, Vijayastelar B. Liju, Joel Joy Koshy, Bijo Mathew, Arun Valsan, Hoon Kim, Lekshmi R. Nath · 2023 · Cancers
12. Low potential of circulating interleukin 1 receptor antagonist as a prediction marker for squamous cell carcinoma of the head and neck
    Linda Boldrup, Philip John Coates, Xiaolian Gu, Lixiao Wang, Robin Fåhræus, Torben Wilms, Nicola Sgaramella, Karin Nylander · 2021 · Journal of Oral Pathology and Medicine
13. The Immunobiology of Cancer: An Update Review
    Anna Meiliana, Nurrani Mustika Dewi, Andi Wijaya · 2017 · The Indonesian Biomedical Journal
14. Mechanisms of Anti-PD Therapy Resistance in Digestive System Neoplasms
    Yuxia Wu, Xiangyan Jiang, Zeyuan Yu, Zongrui Xing, Yong Ma, Huiguo Qing · 2024 · Recent Patents on Anti-Cancer Drug Discovery
15. A Melanoma Brain Metastasis CTC Signature and CTC:B-cell Clusters Associate with Secondary Liver Metastasis: A Melanoma Brain–Liver Metastasis Axis
    Tetiana Y. Bowley, Mireya C. Ortiz, Irina V. Lagutina, Mara P. Steinkamp, Bridget N. Fahy, Bernard Tawfik, Moises Harari-Turquie, Dario Marchetti · 2025 · Cancer Research Communications
16. Can B- cell based immunotherapy be our new perspective to exit cancer?
    Anela Thomas, T. V. Smitha · 2020 · Journal of Oral and Maxillofacial Pathology
17. A novel prognostic model for cutaneous melanoma based on an immune-related gene signature and clinical variables
    Yifan Tang, Huicong Feng, Lupeng Zhang, Chiwen Qu, Jin‐Long Li, Xiangyu Deng, Suye Zhong, Jun Yang, Xiyun Deng, Xiaomin Zeng et al. · 2022 · Scientific Reports
18. Overview of Basic Immunology for Clinical Investigators
    Bettzy Stephen, Joud Hajjar · 2017 · Advances in experimental medicine and biology
19. Non-coding Class Switch Recombination-Related Transcription in Human Normal and Pathological Immune Responses
    Helena Kuri-Magaña, Leonardo Collado‐Torres, Andrew E. Jaffe, Humberto Valdovinos-Torres, Marbella T. Ovilla-Muñoz, Juan Téllez‐Sosa, Laura C. Bonifaz, Jesús Martínez-Barnetche · 2018 · Frontiers in Immunology
20. Dynamic changes in chemosensitivity immune predictors in patients with hypopharyngeal cancer treated with induction chemotherapy
    Wei Sun, Lin Chen, Jin-Qiang Huang, Jian Li, Xiao-Lin Zhu, Yi-Hui Wen, Wei-Ping Wen · 2019 · Head and Neck
21. Cancer stem cells, plasticity, and drug resistance
    Maria Chiara Lionetti, Maria Rita Fumagalli, Caterina A. M. La Porta · 2020 · Cancer Drug Resistance
22. Characterization of Viscum album L. Effect on Immune Escape Proteins PD-L1, PD-L2, and MHC-I in the Prostate, Colon, Lung, and Breast Cancer Cells
    Seema Devi, Carsten Gründemann, Roman Huber, Stefanie Kowarschik · 2023 · Complementary Medicine Research
23. Computational Quantification of Cancer Immunoediting
    Kun Liu, Shengyuan He, Shangqin Sun, Xinxin Zhang, Yanzhen He, Fei Quan, Bo Pang, Yun Xiao · 2023 · Cancer Immunology Research
24. Evaluation of Cytotoxic T Lymphocytes and Natural Killer Cell Distribution in Oral Squamous Cell Carcinoma and Oral Epithelial Dysplasia: An Immunohistochemical Study
    Sneha John, Anna P. Joseph, Varun Raghavan Pillai, Pratibha Ramani, P Jayanthi, Karthikeyan Ramalingam · 2024 · Cureus
25. Chemokines as the critical factors during bladder cancer progression: an overview
    Amir Sadra Zangouei, Amir Abbas Hamidi, Hamid Reza Rahimi, Ehsan Saburi, Majid Mojarrad, Meysam Moghbeli · 2021 · International Reviews of Immunology
26. Manipulation of tumor microenvironment by induction of immunogenic cell death and immune check point inhibitors for enhancing the efficacy of cancer treatments
    Abdullah Moridikia, Soheila Montazersaheb, Ommoleila Molavi · 2026 · Biomedicine & Pharmacotherapy
27. Mammalian Species-Specific Resistance to Mammary Cancer
    Itamar Barash · 2025 · Journal of Mammary Gland Biology and Neoplasia
28. Integrative bioinformatics approaches to establish potential prognostic immune-related genes signature and drugs in the non-small cell lung cancer microenvironment
    Jiao Zhou, Shan Shi, Yeqing Qiu, Zhongwen Jin, Wenyan Yu, Rongzhi Xie, Hongyu Zhang · 2023 · Frontiers in Pharmacology
29. Les anticorps monoclonaux dirigés contre les checkpoints immunologiques : de nouvelles approches d’immunothérapie en onco-hématologie
    Véronique Minard‐Colin · 2016 · Revue d Oncologie Hématologie Pédiatrique
30. Tackling immunomonitoring in gastrointestinal cancer
    Maëlle Anciaux, Caroline Vandeputte, Alain Hendlisz · 2017 · Current Opinion in Oncology
31. The hallmarks of cancer and immunology
    Lara Scheherazade Milane · 2021 · Elsevier eBooks
32. Fatty Acids - From Biosynthesis to Human Health
    Erik Froyen · 2022 · Biochemistry
33. Modulation of cellular transcriptome and proteome composition by azidohomoalanine—implications on click chemistry–based secretome analysis
    Friederike Kirschner, Danielle Arnold-Schild, Christian Leps, Mateusz Krzysztof Łącki, Matthias Klein, Yannic Chen, Annekathrin Ludt, Fédérico Marini, Can Kücük, Lara Stein et al. · 2023 · Journal of Molecular Medicine
34. Head and Neck Tumors
    Moni Abraham Kuriakose, Swagnik Chakrabarti, Sok Ching Cheong, Luiz Paulo Kowalski, TIAGO NOVAES PINHEIRO, Camile Selim Farah · 2018 · Springer eBooks
35. Bourgeoning Cancer Targets
    Priyanka Kriplani · 2022 · Recent Patents on Anti-Cancer Drug Discovery
36. Role of miRNAs in Sigmoid Colon Cancer: A Search for Potential Biomarkers
    Diego Marques, Layse Raynara Ferreira-Costa, Lorenna Larissa Ferreira-Costa, Ana Beatriz Bezerra-Oliveira, Romualdo da Silva Corrêa, Carlos César de Oliveira Ramos, Tatiana Vinasco‐Sandoval, Kátia de Paiva Lopes, Ricardo A. Vialle, Amanda Ferreira Vidal et al. · 2020 · Cancers
37. Immunoediting is not a primary transformation event in a murine model of MLL-ENL AML
    Monika Dudenhöffer‐Pfeifer, David Bryder · 2018 · Life Science Alliance
38. Chinese Medicines and Natural Medicine as Immunotherapeutic Agents for Gastric Cancer: Recent Advances
    Zhipeng Zhang, Ziqi Chen, Zujun Que, Zhihong Fang, Huirong Zhu, Jianhui Tian · 2024 · Cancer Reports
39. Loss of Chemerin in Rhabdomyosarcoma Cells Polarizes Adjacent Monocytes to an Immunosuppressive Phenotype
    Rui Sun, Jia Le Lin, Man Si Cheng, Kang Yi Lee, Thilo Spruß, Christa Buechler, Herbert Schwarz · 2022 · Biomedicines
40. Intratumoral Injection of Large Surface Area Microparticle Taxanes in Carcinomas Increases Immune Effector Cell Concentrations, Checkpoint Expression, and Synergy with Checkpoint Inhibitors: A Review of Preclinical and Clinical Studies
    Gere S. diZerega, Holly A. Maulhardt, Shelagh J. Verco, Alyson M. Marin, Michael Jay Baltezor, Samantha A. Mauro, Marc A. Iacobucci · 2024 · Oncology and Therapy
41. Tumor Infiltrating Lymphocytes in Breast Cancer: Implementation of a New Histopathological Biomarker
    Giuseppe Floris, Glenn Broeckx, Asier Antoranz, Maxim De Schepper, Roberto Salgado, Christine Desmedt, Dieter J. E. Peeters, Gert G. G. M. Van den Eynden · 2022 · Springer eBooks
42. Advances in Radiation Biology of Particle Irradiation
    Alexander Helm, Walter Tinganelli, Marco Durante · 2018 · Progress in tumor research
43. sHLA-G as a biomarker for colorectal cancer pathogenesis
    Sabrine Dhouioui, Nadia Boujelbène, Hanen Chelbi, Inès Zemni, Inès Ben Safta, Hadda‐Imene Ouzari, Amel Mézlini, Abdel Halim Harrath, Vera Rebmann, Inès Zidi · 2021 · Journal of King Saud University - Science
44. Resonance of fatty acid metabolism and immune infiltration in anti-PD-1 monotherapy for breast cancer
    Andi Zhao, Jin Yang, Ran Ran, Shidi Zhao, Yuxin Cui, Fang Hu, Yan Zhou · 2024 · Translational Oncology
45. Neoantigen load as a predictor of relapse in early-stage NSCLC: features that agonise and antagonise prognosis
    Linda Ye, Ian M. Dick, Bruce W. S. Robinson, Jenette Creaney, Alec Redwood · 2025 · Cancer Immunology Immunotherapy
46. Artificial Intelligence and Machine Learning Approaches in Designing Immunotherapy in Cancer
    Lokesh Seth, Colton John Ladbury, Arya Amini · 2025 · Cancer treatment and research
47. Of Barriers and Loops—How Evolution Limits Most Cancer Risks to Older Ages
    Marco De Dominici, James V. DeGregori · 2026 · Cancer Discovery
48. Model‐Based Patient Selection and Dosing Strategies for HRAS and PIK3CA Dysregulated HNSCC : A QSP Model for Alpelisib and Tipifarnib Combination
    Jaehee V. Shim, Douglas Chung, Alison Smith, Shivani Malik, Binaifer Balsara, Francis Burrows, PH van der Graaf, Amitava Mitra · 2026 · Clinical Pharmacology & Therapeutics
49. Mitochondrial transfer-driven immune evasion in the tumor microenvironment
    Li Zhu, Yosuke Togashi · 2026 · International Immunology
50. Effect of anesthetic technique on antitumor immunity in patients undergoing surgery for gall bladder cancer: A prospective randomized comparative study
    Ankit Sharma, Lata Kumari, Brajesh Kumar Ratre, Maroof Ahmad Khan, Sunil Kumar, Rakesh Kumar Deepak, Vinod Kumar, Nishkarsh Gupta, Rakesh Kumar Garg, Seema Mishra et al. · 2024 · International Journal of Cancer
51. Cancer Resistance to Immunotherapy
    Rita Khoury, Annoir Shayya, Cendrella Bou Orm, Osama Zein Deen, Hady Ghanem · 2025 · Immuno
52. Top‐Down Coercive Mechanisms and the Major Transitions in Evolution
    Javier Suárez, Adrian Stencel, Isobel Ronai · 2025 · BioEssays
53. ASSOCIATION OF NKT- AND ACTIVATED CD25+ PERIPHERAL BLOOD LYMPHOCYTES WITH DISEASE FREE AND OVERALL SURVIVAL OF TRIPLE NEGATIVE BREAST CANCER PATIENTS
    Черткова Антонина Ивановна, Славина Елена Григорьевна, Т. Н. Заботина, Кадагидзе Заира Григорьевна, Шоуа Эсма Константиновна, О. О. Гордеева, Irina Vladimirovna Kolyadina, Lyudmila Zhukova, Ганьшина Инна Петровна, Andrey Meshcheryakov · 2020 · Siberian Journal of Oncology
54. Head and Neck Tumors
    Moni Abraham Kuriakose, Swagnik Chakrabarti, Sok Ching Cheong, Luiz Paulo Kowalski, TIAGO NOVAES PINHEIRO, Camile Selim Farah · 2019 · Springer eBooks
55. Kinetic Aspects of the Interplay of Cancer and the Immune System
    Vladimir P. Zhdanov · 2019 · Biophysical Reviews and Letters
56. Post-transplant cancer: An epidemiological evaluation
    Anna Francis, Eric Hoi Kit Au, Wai H. Lim, Germaine Wong · 2020 · Journal of Onco-Nephrology
57. Natural Products as Immunomodulatory and Chemosensitizing Agents in Colon Cancer Treatment
    Sandeep Kumar, Abhishek Goel, Yogendra Shantaram Padwad · 2021 · Springer eBooks
58. Immune System in Action
    Bettzy Stephen, Joud Hajjar · 2021 · Advances in experimental medicine and biology
59. Recent Developments in the Immunotherapeutic Approaches for Cancer Treatment
    Shiv Bharadwaj, Nikhil Kirtipal, R.C. Sobti · 2022 · Springer eBooks
60. Model‐Informed Selection of the Recommended Phase 2 Dosage for Anti‐TIGIT Immunotherapy Leveraging co‐Expressed PD‐1 Inhibitor Target Engagement
    Irina Kareva, Ping Hu, Vadryn Pierre, Thomas Kitzing, Anja Victor, Emilia Richter, Wei Gao, Karthik Venkatakrishnan, Anup Zutshi · 2025 · Clinical Pharmacology & Therapeutics
61. Immunoprevention of non-viral cancers: challenges and strategies for early intervention
    Kajal Biswas, Lillian S. Kuo, Robert H. Shoemaker, Altaf Mohammed · 2025 · Cancer Cell International
62. Neoantigen-based T cell vaccines design strategies, therapeutic barriers, and clinical advances
    Jinglong Shi, Jie Wang, 罗红梅, Qiang Zhao, Zhouchi Yao, Genping Wu, Ze Li, Hong Wang, G D Chen, Daichao Wu · 2026 · Vaccine
63. Dynamic ecosystems of tumor drug resistance mechanisms: from molecular heterogeneity to systemic interventions
    Qiaohong Bao, Hang Chen, Jiali Wu, Yahui Wang, Xinmei Chen, Zhizhe Lin, Youfa Xu, Jianming Chen · 2026 · APOPTOSIS
64. Updated Landscape of the Tumor Microenvironment and Targeting Strategies in an Era of Precision Medicine
    Yu Sun, Paul J. Chiao · 2017 · InTech eBooks
65. Impact of circRNA on the complex regulatory network of the cell
    Caterina A. M. La Porta · 2019 · Non-coding RNA Investigation
66. Intrinsic and acquired cancer immunotherapy resistance
    Reem Saleh, Varun Sasidharan Nair, Salman M. Toor, Eyad Elkord · 2021 · Elsevier eBooks
67. La thérapie cellulaire dans tous ses états
    Aurore Dougé, Christophe Caux, Jacques‐Olivier Bay · 2024 · Bulletin du Cancer
68. Schedule Immunotherapy of Cancer; Current Status and Prospectus
    Khan Mn · 2024 · Virology & Immunology Journal
69. HLA-Based Immunotherapy for Cancer
    Lisa M. James · 2025 · IntechOpen eBooks
70. Gene-based Interventions for Cancer Immunotherapy
    Otto Luiz Dutra Cerqueira, Gissele Rolemberg Oliveira Silva, Igor de Luna Vieira, Marlous Vinícius Gomes Lana, Nadine Gimenez de Assis, Otavio Augusto Rodrigues, Paulo Roberto Del Valle, Samir Andrade Mendonça, Bryan Eric Strauss · 2019 · IntechOpen eBooks
71. Construction of plasmids expressing recombinant B cell epitopes of PD1
    Sofy Meilany, Andrijono Andrijono, Pauline Phoebe Halim, Budiman Bela · 2019 · Health Science Journal of Indonesia
72. The Art of Oncoimmunovaccinomics
    Taruna Ikrar, Dito Anurogo · 2021 · World Journal of Vaccines
73. Changes of Immune Cell Fractions in Patients Treated with Immune Checkpoint Inhibitors
    Hye Ryeon Kim, Jung Hun Kang, Sung Hyun Kim, Hana Kim, Il Hwan Kim, Young Joo Min, Seong Hoon Shin, Sung Yong Oh, Gyeong‐Won Lee, Ji Hyun Lee et al. · 2022 · Cancers
74. Cancer remission due to immune impairment: A review report
    R. Elamathi R · 2022
75. Targeting the PD-1/PD-L1 pathway potentiates immunoediting and changes the dynamics of neutral evolution in a mouse model of colorectal cancer
    Mirjana Efremova, Victoria Klepsch, Pornpimol Charoentong, Francesca Finotello, Dietmar Rieder, Hubert Hackl, Natascha Hermann‐Kleiter, Martin Löwer, Gottfried Baier, Anne Krogsdam et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
76. Viral infection overcomes ineffectiveness of anti-tumoral CD8+ T cell mediated cytotoxicity
    Fan Zhou, Justa Friebus‐Kardash, Hilal Bhat, Vikas Duhan, Sarah-Kim Friedrich, Judith Bezgovsek, Halime Kalkavan, Michael Bergerhausen, Max Schiller, Yara Maria Machlah et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
77. Exploring Naringenin's Cancer-Fighting Potential: An In-depth In-silico Study of Prosomillet Metabolite Targeting the Human Epidermal Growth Factor Receptor
    Pavitra Kathirvel, N. Bharathi, Saranya Nallusamy, Jayakanthan Mannu, Sampathrajan Vellaikumar, V. Anandhi, Ramanathan Sowdhamini, Vikas Ramyagya Tiwari · 2023 · Research Square
78. Multifaceted Aspects of Dysfunctional Myelopoiesis in Cancer and Therapeutic Perspectives with Focus on HCC
    Andrea Arleo, Annapaola Montagner, Catia Giovannini, Fabrizia Suzzi, Fabio Piscaglia, Laura Gramantieri · 2024 · Biomolecules
79. Cancer After Kidney Transplantation
    Renaud Snanoudj, Jacques Dantal, Célèste Lebbé, Christophe M. Legendre · 2017 · Elsevier eBooks
80. Monoclonal Antibodies Targeting the Immune System
    Véronique Minard‐Colin · 2017 · Springer eBooks
81. Overview of Dendritic Cell Vaccines for Brain Tumors
    Richard G. Everson, Linda M. Liau · 2018 · Elsevier eBooks
82. The role of intraepithelial lymphocytes and type 2 immunity for tissue homeostasis and carcinogenesis in the skin
    Timothy D'Alessandri · 2016
83. Signal Transduction in Radiation Oncology
    Nils Cordes, Josephine Görte, Irina Korovina, Sarah Förster · 2019 · Springer eBooks
84. Cellular Therapy for Melanoma
    Udai S. Kammula, Michael T. Lotze · 2018 · Springer eBooks
85. IL-33 no carcinoma espinocelular de pele
    Vanessa Garcia Vilas Boas · 2018 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
86. Immune Checkpoint Inhibitors: A Step forward in Cancer Management
    Maria Rosaria Carratù, Maria Assunta Potenza, Carmela Nacci, Domenico De Rasmo, Anna Signorile · 2019 · Madridge Journal of Oncogenesis
87. Evolution of immune escape mechanisms in the progression from preinvasive to invasive human lung adenocarcinoma
    Nasser Khaled Altorki, Alain Borczuk, Vivek Mittal, Olivier Elemento, Timothy E. McGraw · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
88. Immune Modulation in Interventional Oncology
    Johannes Maximilian Ludwig, Michael Cecchini, Hyun S. Kim · 2020 · Springer eBooks
89. An immune-centric investigation of Coronavirus in the women with cancers; A review article
    Seyedeh Reyhaneh Yousefi Sharami, Azadeh Yousefnezhad, Fahimeh Nokhostin · 2021 · Journal of Family Medicine and Primary Care
90. The Link between Cancer, Autoimmunity and Diabetes
    Domina Petrić · 2021
91. Prognostic value of peripheral blood lymphocyte subsets in patients with solid cancers: a retrospective study
    ", M.E. Panait, Antonela Busca, Ana-Maria Coman, Mariana Saulea, Madalina Bolovan · 2021 · Archives of the Balkan Medical Union
92. Is it Time to Reconsider and Re-Stratergise B Lymphocyte Based Immunotherapy?
    Smitha T, Anela Thomas · 2022 · Journal of Vaccines Immunology and Immunopathology
93. Cellular Therapy for Melanoma
    Udai S. Kammula, Michael T. Lotze · 2020 · Springer eBooks
94. Cancer and Immune System: Systematic Review
    Ali AYTAÇ, Sabri Barutça · 2022 · Turkiye Klinikleri Journal of Internal Medicine
95. Faculty Opinions recommendation of Neoantigens generated by individual mutations and their role in cancer immunity and immunotherapy.
    Laurence Crane Eisenlohr, Gabriela L. Cosma · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
96. Peer Review #1 of "Exosomal cargoes in OSCC: current findings and potential functions (v0.1)"
    2020 · PeerJ
97. Peer Review #3 of "Exosomal cargoes in OSCC: current findings and potential functions (v0.1)"
    2020 · PeerJ
98. Peer Review #2 of "Exosomal cargoes in OSCC: current findings and potential functions (v0.1)"
    2020 · PeerJ
99. Faculty Opinions recommendation of Cancer immunotherapy: harnessing the immune system to battle cancer.
    Giancarlo Vecchio, Rosa Marina Melillo · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
100. Therapeutic Potential of Canakinumab Targeting the Inflammatory Cytokine Interleukin-1β for Non-small-cell Lung Cancer
     Yasushi Goto · 2022 · Haigan